Pricing Log in Create free account

Brainstorm Cell Therapeutics Inc. (BCLI) vs XTL Biopharmaceuticals Ltd. (XTLB)

Brainstorm Cell Therapeutics Inc. and XTL Biopharmaceuticals Ltd. are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and XTL Biopharmaceuticals Ltd. are of similar size ($7.3M and $7.0M). Across the 8 metrics below, XTL Biopharmaceuticals Ltd. leads on 5 and Brainstorm Cell Therapeutics Inc. on 3.

Valuation

Metric BCLI XTLB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.07 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.99 9.02
Earnings yield (103.48%) (31.56%) (32.88%)
Free cash flow yield (40.91%) (176.08%) (23.13%)

Profitability

Metric BCLI XTLB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 119.20% 0.00% (51.96%)
Return on assets (627.43%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCLI XTLB Biotechnology median
Revenue growth (TTM) — (12.71%) 6.76%
EPS growth (last fiscal year) 51.95% (409.84%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCLI XTLB Biotechnology median
Debt to equity (0.11) (1.83) 0.00
Current ratio 0.03 0.70 4.97
Net debt to EBITDA (0.10) (0.11) 1.01

Dividend

Metric BCLI XTLB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCLI XTLB Biotechnology median
Market cap 6.99m 7.25m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack